This in-person program is for healthcare professionals and offers continuing education (CE) and continuing medical education (CME) credit.
This activity has been designed to meet the educational needs of healthcare providers that treat patients with chronic leukemia.
At the conclusion of this program, participants will be able to:
- Describe the latest clinical data on prognostic indicators that can be used to inform a specific treatment plan for patients with CLL or CML
- Identify criteria for response assessment and molecular monitoring in the treatment of chronic leukemias
- Consider emerging clinical data on novel agents and emerging therapeutic strategies that have the potential to improve the outcomes for patients with chronic leukemia
- Address potential barriers to treatment adherence for chronic leukemias
Steven Coutre, MD
Professor of Medicine
Palo Alto, CA
Neil Shah, MD, PhD
Professor, Department of
Program Leader, Hematopoietic
Malignancies Program, UCSF
Helen Diller Comprehensive
Cancer Center UCSF
San Francisco, CA
Lauren Berger, MPH – Leukemia & Lymphoma Society
Defining Treatment Goals and Choice of Optimal Kinase Inhibitor Therapy in Chronic Phase CML
Changing the Treatment Paradigm: Upfront Management of CLL
Extending Survival: Choices of Therapy for the Relapsed CLL Patient
|8:30 pm||Closing Remarks|
CME/CE Continuing Education Information
In support of improving patient care, Rush University Medical Center is accredited by the American Nurses Credentialing Center (ANCC), the Accreditation Council for Pharmacy Education (ACPE), and the Accreditation Council for Continuing Medical Education (ACCME), to provide continuing education for the healthcare team.
Rush University Medical Center designates this Live Activity for a maximum of two (2) AMA PRA Category 1 Credits™. Physicians should claim only credit commensurate with the extent of their participation in the activity.
Rush University is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation. Rush University designates this live activity for two (2) Continuing Education credits. This activity provides 2.0 ONCC credit hours. This activity will fulfill Category 2 contact hour requirements for pharmacology for ANCC certified advanced practice nurses.
This program is approved for 2.0 hours (0.2 CEUs) of continuing pharmacy education credit. Proof of participation will be posted to your NABP CPE profile within 4 to 6 weeks to participants who have successfully completed the posttest. Participants must participate in the entire presentation and complete the course evaluation to receive continuing pharmacy education credit.
Instructions for Credit
There is no fee for this educational activity. To receive credit for this CME/ CE activity, complete the preassessment, course, post-assessment, and evaluation and return it to the on-site coordinator. Your certificate of credit will be e-mailed to you within 4 weeks.
For additional information, questions, grievances, or assistance with special needs (physical, dietary, etc.) please contact us prior to the program, email email@example.com or call 1-866-607-4333.
Sponsors and Supporters
This program is supported by educational grants received from AbbVie and Janssen Biotech, Inc.
This activity is jointly provided by The Leukemia & Lymphoma Society, PleXus Communications, and RUSH University.